ZA967545B - Pharmaceuticals. - Google Patents

Pharmaceuticals.

Info

Publication number
ZA967545B
ZA967545B ZA9607545A ZA967545A ZA967545B ZA 967545 B ZA967545 B ZA 967545B ZA 9607545 A ZA9607545 A ZA 9607545A ZA 967545 A ZA967545 A ZA 967545A ZA 967545 B ZA967545 B ZA 967545B
Authority
ZA
South Africa
Prior art keywords
pharmaceuticals
Prior art date
Application number
ZA9607545A
Other languages
English (en)
Inventor
Hidero Akiyama
Zene Matsumoto
Takashi Ueno
Original Assignee
Smithkline Beecham Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Seiyaku Kk filed Critical Smithkline Beecham Seiyaku Kk
Publication of ZA967545B publication Critical patent/ZA967545B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9607545A 1995-09-09 1996-09-06 Pharmaceuticals. ZA967545B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9518465.1A GB9518465D0 (en) 1995-09-09 1995-09-09 Pharmaceuticals

Publications (1)

Publication Number Publication Date
ZA967545B true ZA967545B (en) 1998-05-12

Family

ID=10780470

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9607545A ZA967545B (en) 1995-09-09 1996-09-06 Pharmaceuticals.

Country Status (15)

Country Link
US (3) US6242008B1 (de)
EP (1) EP0850048B1 (de)
JP (1) JP2000504309A (de)
AR (1) AR004196A1 (de)
AT (1) ATE269695T1 (de)
AU (1) AU6889396A (de)
CO (1) CO4750645A1 (de)
CY (1) CY2584B2 (de)
DE (1) DE69632787T2 (de)
ES (1) ES2224175T3 (de)
GB (1) GB9518465D0 (de)
PT (1) PT850048E (de)
TW (1) TW426525B (de)
WO (1) WO1997010810A2 (de)
ZA (1) ZA967545B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000128774A (ja) * 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
US6858725B1 (en) 1999-11-12 2005-02-22 R.P. Scherer Technologies, Inc. Microcrystalline cellulose cushioning granules
EP1244728B1 (de) * 1999-11-12 2005-03-02 R.P. Scherer Technologies, Inc. Dämpfgranulate aus mikrokristalliner cellulose
GB0010446D0 (en) * 2000-04-28 2000-06-14 Glaxo Wellcome Kk Pharmaceutical formulation
US6958908B2 (en) * 2003-05-30 2005-10-25 Hubbell Incorporated Compact enclosure for interchangeable SONET multiplexer cards and methods for using same
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
EP2654089A3 (de) 2007-02-16 2015-08-12 Nanogram Corporation Solarzellenstrukturen, Fotovoltaikmodule und entsprechende Verfahren
WO2010001574A1 (ja) 2008-07-01 2010-01-07 沢井製薬株式会社 タムスロシン塩酸塩を含有する球形微粒子の製造方法
US20130071456A1 (en) * 2010-06-23 2013-03-21 Colgate-Palmolive Company Encapsulation of ingredients in lactose matrix to form active encapsulates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713245A (en) * 1984-06-04 1987-12-15 Mitsui Toatsu Chemicals, Incorporated Granule containing physiologically-active substance, method for preparing same and use thereof
CA1331713C (en) * 1988-12-29 1994-08-30 Hitoshi Iijima Granular composition for ruminant
DE59105613D1 (de) 1990-08-24 1995-07-06 Spirig Ag Verfahren zur Herstellung von Pellets.
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
JP3316243B2 (ja) * 1993-01-18 2002-08-19 川鉄鉱業株式会社 粉末シリカの高分散性造粒物及びその製造方法
IT1264020B (it) * 1993-01-28 1996-09-09 Recordati Chem Pharm Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
AU6889396A (en) 1997-04-09
DE69632787T2 (de) 2005-08-18
TW426525B (en) 2001-03-21
WO1997010810A2 (en) 1997-03-27
CY2584B2 (en) 2009-11-04
WO1997010810A3 (en) 1997-06-05
DE69632787D1 (de) 2004-07-29
US6410055B1 (en) 2002-06-25
EP0850048A2 (de) 1998-07-01
US20030072809A1 (en) 2003-04-17
US6242008B1 (en) 2001-06-05
PT850048E (pt) 2004-09-30
JP2000504309A (ja) 2000-04-11
CO4750645A1 (es) 1999-03-31
ES2224175T3 (es) 2005-03-01
AR004196A1 (es) 1998-11-04
GB9518465D0 (en) 1995-11-08
EP0850048B1 (de) 2004-06-23
ATE269695T1 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
ZA967315B (en) Biphenylamides.
MX213417B (es) Fenilpiridazinonas.
ZA9610858B (en) Heteroclyclic compounds.
ZA961444B (en) Pyrazolylbenzoyl derivatives.
ZA964468B (en) Triazolylmethyl-cyclopentanols.
ZA961955B (en) Indazolecarboxamides.
DE69610844D1 (en) Hydroformylierungsverfahren.
ZA967545B (en) Pharmaceuticals.
PL326837A1 (en) 25-hydroxy-16-ene-26, 27-bishomocholecarctiferoles
ZA966399B (en) Endothelin-receptor-antagonists.
ZA964560B (en) Anit-viral compounds.
ZA9610589B (en) Pharmaceutical compounds.
ZA97310B (en) Pharmaceuticals.
ZA966933B (en) Endothelin-receptor-antagonists.
ZA966750B (en) Halogenobenzimidazoles.
ZA967314B (en) Carbamoylcarboxamides.
ZA969560B (en) Substituted 1-methyl-3-phenylpyrazoles.
ZA968953B (en) 24-homo-26,27-hexafluoro-cholecalciferols
GB9505548D0 (en) Pharmaceuticals
GB9511850D0 (en) Pharmaceuticals
GB9525938D0 (en) Pharmaceuticals
GB9526703D0 (en) Pharmaceuticals
GB9513208D0 (en) Pharmaceuticals
GB9513209D0 (en) Pharmaceuticals
GB9520678D0 (en) Pharmaceuticals